Assessing multiple medication use with probabilities of benefits and harms

Journal of Aging and Health

Volumn 20, Issue 6, 2008, Pages 694-709

  Murphy, Terrence E ^a   Agostini, Joseph V ^b   Van Ness, Peter H ^a   Peduzzi, Peter ^b   Tinetti, Mary E ^a   Allore, Heather G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adverse effects; Aging; Multiple medications; Trade offs; Utility function

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPERTENSIVE AGENT; LEVODOPA; NONSTEROID ANTIINFLAMMATORY AGENT; OLANZAPINE; PARACETAMOL; PLACEBO; PRAMIPEXOLE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANTICHOLINERGIC EFFECT; ARTHRITIS; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DIZZINESS; EJACULATION; EXTRAPYRAMIDAL SYMPTOM; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL SYMPTOM; GEOMETRY; HEALTH CARE UTILIZATION; HUMAN; HYPERTENSION; INSOMNIA; MALE; MEDICAL LITERATURE; OUTCOME ASSESSMENT; PARAMETER; PARKINSON DISEASE; PROBABILITY; QUANTITATIVE ANALYSIS; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; SEXUAL DYSFUNCTION; SIDE EFFECT; SOMNOLENCE; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

AGED; DRUG THERAPY; HEALTH SERVICES FOR THE AGED; HUMANS; MODELS, STATISTICAL; POLYPHARMACY; UNITED STATES;

EID: 49749121880     PISSN: 08982643     EISSN: 15526887     Source Type: Journal    
DOI: 10.1177/0898264308321006     Document Type: Article

References (36)

1. Agostini, J.V. (2007). Measuring drug burden: A step forward. Archives of Internal Medicine, 167, 753-754.
2. Applegate, W.B., Pressel, S., Wittes, J., Luhr, J., Shekelle, R.B., Camel, G.H., et al. (1994). Impact of the treatment of isolated systolic hypertension on behavioral variables: Results from the systolic hypertension in the elderly program (SHEP). Archives of Internal Medicine, 154, 2154-2160.
3. Beers, M.H. (1997). Explicit criteria for determining potentially inappropriate medication use by the elderly. Archives of Internal Medicine, 157, 1531-1536.
4. Beers, M.H., Ouslander, J.G., Rollingher, H., Reuben, D.B., & Beck, J.C. (1991). Explicit criteria for considering inappropriate medication use in nursing home residents. Archives of Internal Medicine, 151, 1825-1832.
5. Brennan, P.F., & Strombon, I. (1998). Improving health care by understanding patient preferences: The role of computer technology. Journal of the American Medical Informatics Association, 5, 257-262.
6. Colley, C.A., & Lucas, L.M. (1993). Polypharmacy: The cure becomes the disease. Journal of General Internal Medicine, 8, 278-283.
7. Cranney, A., Wells, G., Willan, A., Griffith, L., Zytaruk, N., Robinson, V., et al. (2002). Meta-analysis of alendronate for the treatment of postmenopausal women. Endocrine Reviews, 23, 508-516.
8. Fick, D.M., Cooper, J.W., Wade, W.E., Waller, J.L., Maclean, J.R., & Beers, M.H. (2003). Updating the Beers criteria for potentially inappropriate medication use in older adults. Archives of Internal Medicine, 163, 2716-2724.
9. Golden, A.G., Preston, R.A., Barnett, S.D., Liorente, M., Hamdan, K., & Silverman, M.A. (1999). Inappropriate medication prescribing in homebound older adults. Journal of General Internal Medicine, 47, 948-953.
10. Hansen, R.A., Greene, S.B., Williams, C.E., Blalock, S.J., Crook, K.D., Askers, R., et al. (2006). Types of medication errors in North Carolina nursing homes: A target for quality improvement. American Journal of Geriatric Pharmacotherapy, 4, 52-61.
11. Harrington, E. (1965). The desirability function. Industrial Quality Control, 21, 494-498.
12. Hulley, S.B., Furberg, C.D., Gurland, B., McDonald, R., Perry, H.M., Schnaper, H.W., et al. (1985). Systolic hypertension in the elderly (SHEP): Antihypertensive efficacy of chlorthalidone. American Journal of Cardiology, 56, 913-920.
13. Jahingir, M.N., & Huque, Z. (2005). Design optimization of rocket-based combined-cycle inlet/ejector system. Journal of Propulsion and Power, 21, 650-661.
14. Jayaram, M.B., Hosalli, P., & Stroup, S. (2006). Risperidone versus olanzapine for schizophrenia. Cochrane Database of Systematic Reviews, April(2). 1-85.
15. Kaufman, D.W., Kelly, J.P., & Rosenberg, L. (2002). Recent patterns of medication use in the ambulatory adult population of the United States. Journal of the American Medical Association, 287, 337-344.
16. LaRosa, J.C., Jiang, H., & Vupputuri, S. (1999). Effect of statins on risk of coronary disease. Journal of the American Medical Association, 282, 2340-2346.
17. Lenert, L.A., & Cher, D.J. (1999). Use of meta-analytic results to facilitate shared decision making. Journal of the American Medical Informatics Association, 6, 412-419.
18. Lip, G.Y.H., & Felmeden, D.C. (2004). Antiplatelet agents and anticoagulants for hypertension (Review). Cochrane Database of Systematic Reviews, 2004 (3). 1-19.
19. Moayyedi, P., Soo, S., Deeks, J., Delaney, B., Innes, M., Forman, D. (2006). Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database of Systematic Reviews, 2006 (4). 1-96.
20. Monette, J., Gurwitz, J.H., & Avorn, J. (1995). Epidemiology of adverse drug events in the nursing home setting. Drugs and Aging, 7, 203-211.
21. Mort, J.R., & Aparasu, R.R. (2000). Prescribing potentially inappropriate psychotropic medications to the ambulatory elderly. Archives of Internal Medicine, 160, 2825-2831.
22. Mulrow, C., Lau, J., Cornell, J., & Brand, M. (1998). Pharmacotherapy for hypertension in the elderly (Review). Cochrane Database of Systematic Reviews, 1998 (2). 1-38.
23. Murphy, T.E., Van Ness, P.H., Peduzzi, P., Tinetti, M.E., & Allore, H.G. (2006). Mapping usefulness of clinical outcomes: The desirability function. Paper presented at the Proceedings of the Joint Statistical Meetings, Seattle, WA.
24. Narendra, C., Srinath, M.S., & Prakash, R.B. (2005). Development of three layered buccal compact containing metoprolol tartrate by statistical optimization technique. International Journal of Pharmaceutics, 304, 102-114.
25. Nolan, L., & O' Malley, K. (1988). Part I: Sensitivity of the elderly to adverse drug reactions. Journal of American Geriatrics Society, 36, 142-149.
26. Parkinson Study Group. (2000). Pramipexole versus Levodopa as intial treatment for Parkinson disease. Journal of the American Medical Association, 284, 1931-1938.
27. Perry, H.M., Smith, W.M., McDonald, R.H., Black, D., Cutler, J.A., Furberg, C.D., et al. (1989). Systolic hypertension in the elderly program, pilot study (SHEP-PS): Morbidity and mortality experience. Stroke, 20, 4-13.
28. Rochon, P.A., & Gurwitz, J.H. (1997). Optimizing drug treatment for elderly people: The prescribing cascade. British Medical Journal, 315, 1096-1099.
29. Ruland, C.M. (1999). Decision support for patient preference-based care planning. Journal of the American Medical Informatics Association, 6, 304-312.
30. SHEP Cooperative Research Group. (1991). Prevention of stroke by anti-hypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the systolic hyperension in the elderly program (SHEP). Journal of the American Medical Association, 265, 3255-3264.
31. Steffens, D.C., Krishnan, K.R.R., & Helms, M. (1997). Are SSIs better than TCAs? Comparison of SSRIs and TCAs: A meta-analysis. Depression and Anxiety, 6, 10-18.
32. Tinetti, M.E. (1987). Factors associated with serious injury during falls by ambulatory nursing home residents. Journal of American Geriatrics Society, 35, 644-648.
33. Tinetti, M.E., & Speechley, M. (1989). Prevention of falls among the elderly. New England Journal of Medicine, 320, 1055-1059.
34. Tinetti, M.E., Speechley, M., & Ginter, S.F. (1988). Risk factors for falls among elderly persons living in the community. New England Journal of Medicine, 319, 1701-1707.
35. Towheed, T.E., Maxwell, L., Judd, M.G., Catton, M., Hochberg, M.C., & Wells, G. (2006). Acetaminophen for osteoarthritis. Cochrane Database of Systematic Reviews, 2006 (2). 1-56.
36. Wysonge, C.S., Bradley, H., Mayosi, B.M., Maroney, R., Mbewu, A., Opie, L.H., et al. (2007). Beta-blockers for hypertension (Review). Cochrane Database of Systematic Reviews, 2007 (1). 1-42.